Unknown

Dataset Information

0

Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells.


ABSTRACT: Platelet demand has increased around the world. However, the inadequacy of donors, the risk of transfusion-transmitted infections and associated reactions, and the refractory nature of platelet transfusions are among the limitations of allogeneic platelet transfusions. To alleviate these problems, we propose generating platelets in a laboratory that do not induce alloimmunity to human leukocyte antigen (HLA) class I, which is a major cause of immune reaction in platelet transfusion refractoriness. Induced pluripotent stem cells (iPSCs) were generated from peripheral blood mononuclear cells (PBMCs) of a healthy Thai woman. We then knocked out the ?2-microglobulin (?2m) gene in the cells using paired CRISPR/Cas9 nickases and sequentially differentiated the cells into haematopoietic stem cells (HSCs), megakaryocytes (MKs) and platelets. Silencing of HLA class I expression was observed on the cell surface of ?2m-knockout iPSCs, iPSC-derived HSCs, MKs and platelets. The HLA-universal iPSC-derived platelets were shown to be activated, and they aggregated after stimulation. In addition, our in vivo platelet survival experiments demonstrated that human platelets were detectable at 2 and 24?hours after injecting the ?2m-KO MKs. In summary, we successfully generated functional iPSC-derived platelets in vitro without HLA class I expression by knocking out the ?2m gene using paired CRISPR/Cas9 nickases.

SUBMITTER: Norbnop P 

PROVIDER: S-EPMC7242456 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells.

Norbnop Phatchara P   Ingrungruanglert Praewphan P   Israsena Nipan N   Suphapeetiporn Kanya K   Shotelersuk Vorasuk V  

Scientific reports 20200521 1


Platelet demand has increased around the world. However, the inadequacy of donors, the risk of transfusion-transmitted infections and associated reactions, and the refractory nature of platelet transfusions are among the limitations of allogeneic platelet transfusions. To alleviate these problems, we propose generating platelets in a laboratory that do not induce alloimmunity to human leukocyte antigen (HLA) class I, which is a major cause of immune reaction in platelet transfusion refractorines  ...[more]

Similar Datasets

| S-EPMC4235139 | biostudies-literature
| S-EPMC3913921 | biostudies-literature
| S-EPMC5023513 | biostudies-literature
| S-EPMC3897468 | biostudies-literature
| S-EPMC7103130 | biostudies-literature
| S-EPMC7154707 | biostudies-literature
| S-EPMC7060311 | biostudies-literature
| S-EPMC6525926 | biostudies-literature
| S-EPMC2925460 | biostudies-literature
| S-EPMC3464077 | biostudies-literature